NORWAY MEDICAL AS
Operating
Produktutvikling, produksjon, markedsføring, salg og
konsulenttjenester innenfor medisin og helse området samt tilgrensende
områder og annen virksomhet naturlig knyttet til dette, herunder å
delta i andre selskaper som driver liknende virksomhet ved
aksjetegning eller på annen måte. I tillegg skal selskapet drive kjøp
og salg av aksjer og verdipapirer.
Produktutvikling, produksjon, markedsføring og salg innenfor det
medisinsk-tekniske område samt tilgrensende områder og annen
virksomhet naturlig knyttet til dette. I tillegg blir det salg av
konsulenttjenester til det medisinske markedet. Salg og produksjon av
utstyr utføres internasjonalt både til sluttkunder og agenter. I
tillegg skal selskapet drive kjøp og salg av aksjer og verdipapirer.
Organization
- CEO
- AY
Andreas Ystgaard1971
- Chairman of the board
- AY
Andreas Ystgaard1971
- Years since formation
- 9 years
- since Feb 10, 2017
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 100,000
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Annual total result 2025
- 111,291
- NOK
- Total equity 2025
- 2,980,639
- NOK
Last update: Mar 24, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
AY 1971 | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
AY 1971 | Chairman | - |
MO | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
YA 1971 | - | 100 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
YA 1971 | Ordinary shares | 100,000 | 100 % |
Shares owned by the NORWAY MEDICAL AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 5,000 | < 0.01 % | |
| Ordinary shares | 15,000 | < 0.01 % | |
| Ordinary shares | 10,200 | < 0.01 % | |
| Ordinary shares | 5,200 | < 0.01 % | |
| Ordinary shares | 5,500 | < 0.01 % | |
| Ordinary shares | 500 | < 0.01 % |
Last update: Sep 25, 2026
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 9,020 |
Annual Total Result | 111,291 | -68,143 | 24,826 | 259,263 |
Total assets | 2,980,639 | 2,895,883 | 2,975,213 | 2,944,431 |
Total liabilities | 0 | 26,535 | 37,722 | 31,766 |
Total equity | 2,980,639 | 2,869,348 | 2,937,490 | 2,912,665 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 9,020 |
Total operating costs | 114,901 | 108,350 | 100,848 | 305,213 |
Operating result | -114,901 | -108,350 | -100,848 | -296,193 |
Financial income/costs | 226,193 | 40,208 | 125,674 | 555,456 |
Profit before tax | 111,291 | -68,143 | 24,826 | 259,263 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 |
Annual Total Result | 111,291 | -68,143 | 24,826 | 259,263 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total fixed assets | 0 | 0 | 0 | 0 |
Total current assets | 2,980,639 | 2,895,883 | 2,975,213 | 2,944,431 |
Total assets | 2,980,639 | 2,895,883 | 2,975,213 | 2,944,431 |
Short term debt | 0 | 26,535 | 37,722 | 31,766 |
Long term debt | 0 | 0 | 0 | 0 |
Total liabilities | 0 | 26,535 | 37,722 | 31,766 |
Contributed capital | 94,430 | 94,430 | 94,430 | 94,430 |
Retained earnings | 2,886,209 | 2,774,918 | 2,843,060 | 2,818,235 |
Total equity | 2,980,639 | 2,869,348 | 2,937,490 | 2,912,665 |
Total equity and liabilities | 2,980,639 | 2,895,883 | 2,975,213 | 2,944,431 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification